Cargando…
The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
Two hydroxyl containing dithiocarbamates, sodium N-methyl-D-glucamine dithiocarbamate (NaG) and sodium dihydroxyethyl dithiocarbamate (NaY) have been examined as agents for the control of the renal dysfunction in rats given cisplatin. Of these, NaG was found to be the more effective in controlling s...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971790/ https://www.ncbi.nlm.nih.gov/pubmed/1847647 |
_version_ | 1782134985930571776 |
---|---|
author | Reznik, L. V. Myazina, E. M. Shakchmatova, E. I. Gambaryan, S. P. Brovtsyn, V. K. Natochin, Y. V. Jones, M. M. |
author_facet | Reznik, L. V. Myazina, E. M. Shakchmatova, E. I. Gambaryan, S. P. Brovtsyn, V. K. Natochin, Y. V. Jones, M. M. |
author_sort | Reznik, L. V. |
collection | PubMed |
description | Two hydroxyl containing dithiocarbamates, sodium N-methyl-D-glucamine dithiocarbamate (NaG) and sodium dihydroxyethyl dithiocarbamate (NaY) have been examined as agents for the control of the renal dysfunction in rats given cisplatin. Of these, NaG was found to be the more effective in controlling such renal dysfunction when administered at 1 and 3 h after 5 mg cisplatin kg-1, i.p. Renal function was examined 5 days after the administration of cisplatin by measurement of serum and urinary levels of creatinine and urea, creatinine clearance, serum and urinary levels of Na+, K+, Mg2+, Ca2+, as well as the concentrations of these ions in the renal medulla and cortex. Treatment of rats given cisplatin with NaG at 1 and 3 h post cisplatin resulted in indices of renal function which were not significantly different from those of animals which had received no cisplatin. The sole difference was found to be a slight increase in renal cortical Na+ concentration. |
format | Text |
id | pubmed-1971790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19717902009-09-10 The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. Reznik, L. V. Myazina, E. M. Shakchmatova, E. I. Gambaryan, S. P. Brovtsyn, V. K. Natochin, Y. V. Jones, M. M. Br J Cancer Research Article Two hydroxyl containing dithiocarbamates, sodium N-methyl-D-glucamine dithiocarbamate (NaG) and sodium dihydroxyethyl dithiocarbamate (NaY) have been examined as agents for the control of the renal dysfunction in rats given cisplatin. Of these, NaG was found to be the more effective in controlling such renal dysfunction when administered at 1 and 3 h after 5 mg cisplatin kg-1, i.p. Renal function was examined 5 days after the administration of cisplatin by measurement of serum and urinary levels of creatinine and urea, creatinine clearance, serum and urinary levels of Na+, K+, Mg2+, Ca2+, as well as the concentrations of these ions in the renal medulla and cortex. Treatment of rats given cisplatin with NaG at 1 and 3 h post cisplatin resulted in indices of renal function which were not significantly different from those of animals which had received no cisplatin. The sole difference was found to be a slight increase in renal cortical Na+ concentration. Nature Publishing Group 1991-02 /pmc/articles/PMC1971790/ /pubmed/1847647 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Reznik, L. V. Myazina, E. M. Shakchmatova, E. I. Gambaryan, S. P. Brovtsyn, V. K. Natochin, Y. V. Jones, M. M. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
title | The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
title_full | The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
title_fullStr | The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
title_full_unstemmed | The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
title_short | The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
title_sort | prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971790/ https://www.ncbi.nlm.nih.gov/pubmed/1847647 |
work_keys_str_mv | AT rezniklv thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT myazinaem thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT shakchmatovaei thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT gambaryansp thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT brovtsynvk thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT natochinyv thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT jonesmm thepreventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT rezniklv preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT myazinaem preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT shakchmatovaei preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT gambaryansp preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT brovtsynvk preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT natochinyv preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates AT jonesmm preventionofcisplatininducedrenaldysfunctionbyhydroxylcontainingdithiocarbamates |